AU2002341207A1 - Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing - Google Patents

Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing

Info

Publication number
AU2002341207A1
AU2002341207A1 AU2002341207A AU2002341207A AU2002341207A1 AU 2002341207 A1 AU2002341207 A1 AU 2002341207A1 AU 2002341207 A AU2002341207 A AU 2002341207A AU 2002341207 A AU2002341207 A AU 2002341207A AU 2002341207 A1 AU2002341207 A1 AU 2002341207A1
Authority
AU
Australia
Prior art keywords
rnasel
prophylaxis
diagnosis
treatment
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002341207A
Inventor
Andreas Goppelt
Jorn-Peter Halle
Johannes Regenbogen
Birgit Reitmaier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Switch Biotech AG
Original Assignee
Switch Biotech AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001122206 external-priority patent/DE10122206A1/en
Application filed by Switch Biotech AG filed Critical Switch Biotech AG
Publication of AU2002341207A1 publication Critical patent/AU2002341207A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/53—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
AU2002341207A 2001-05-08 2002-05-08 Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing Abandoned AU2002341207A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10122206.8 2001-05-08
DE2001122206 DE10122206A1 (en) 2001-05-08 2001-05-08 Novel use of 2',5'-oligoadenylate synthetase or RNAseL polypeptides, nucleic acids encoding polypeptides, cell expressing peptides and nucleic acids or antibody for analyzing, diagnosing, or treating wound healing
US32294901P 2001-09-17 2001-09-17
US60/322,949 2001-09-17
PCT/EP2002/005113 WO2002090552A2 (en) 2001-05-08 2002-05-08 Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing

Publications (1)

Publication Number Publication Date
AU2002341207A1 true AU2002341207A1 (en) 2002-11-18

Family

ID=26009247

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002341207A Abandoned AU2002341207A1 (en) 2001-05-08 2002-05-08 Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing

Country Status (2)

Country Link
AU (1) AU2002341207A1 (en)
WO (1) WO2002090552A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0208928D0 (en) * 2002-04-19 2002-05-29 Imp College Innovations Ltd Methods
NZ591879A (en) * 2003-10-23 2012-11-30 Kineta Two Llc Detection of mutations in a gene associated with resistance to viral infection, OAS1
EP2267154A1 (en) 2003-10-23 2010-12-29 Illumigen Biosciences, Inc. Oligoadenylate synthetase
TWI415944B (en) * 2004-02-06 2013-11-21 Kineta Two Llc Detection of mutations in a gene associated with resistance to viral infection, oasi
UA95446C2 (en) 2005-05-04 2011-08-10 Іллюміджен Байосайєнсіз, Інк. Mutations in oas1 genes
EP2123748A1 (en) * 2008-05-20 2009-11-25 Institut Pasteur 2'-5'-oligoadenylate synthetase 3 for preventing and treating positive-sense single-stranded rna virus infection
US20110104138A1 (en) * 2009-11-03 2011-05-05 Institut Pasteur Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses
CN115595315A (en) * 2021-06-28 2023-01-13 四川大学华西医院（Cn） Novel application of ribonuclease I in pain inhibition medicine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0797998A4 (en) * 1995-11-17 2003-01-15 Toray Industries Endothelial cell protective

Also Published As

Publication number Publication date
WO2002090552A2 (en) 2002-11-14
WO2002090552A3 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
AU2001284857A1 (en) Surgical instrumentation and method for treatment of the spine
WO2003023008A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AUPR839001A0 (en) Dosage form, device and methods of treatment
IL159067A0 (en) METHODS FOR PREPARATION AND USE OF 1alpha,24 (S) -DIHYDROXYVITAMIN D2
AU2002341207A1 (en) Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing
EP1487864A4 (en) Therapeutic polypeptides nucleic acids encoding same, and methods of use
AU2002356534A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1446419A4 (en) Therapeutic polypeptides, nucleic acids encoding the same, and methods of use
EP1578723A3 (en) Process for the preparation of oxazolidinones and method of use thereof
AU2002367959A1 (en) Process for the preparation of oxazolidinones and method of use thereof
EP1432726A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1401858A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003040330A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1532238A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003083039A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1399537A4 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
AU2002364696A8 (en) Crystalline neutrokine-alpha protein, method of preparation thereof, and method of use thereof
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
EP1225913B8 (en) Use of nitric oxide for the treatment of airway constriction
AU2003279247A1 (en) The use of bacterial phage associated lysing proteins for treating bacterial dental caries
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
AU2002365216A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
PL350128A1 (en) Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
AU2002368208A1 (en) Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax
AU2002313005B2 (en) Use of glycoprotein for the treatment and re-epithelisation of wounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase